NSE: LAURUSLABS
LAURUS LABS LIMITED
Price history
+35.99% over 3M
Performance
52-week range
Position in day range
LAURUSLABS stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹1,741.18
RSI (14)
64
Neutral momentum
Volatility (ATR)
2.67%
Moderate
Close streak
1d down
Volume vs 20d avg
0.30x
From 52W high
-0.51%
Up from 52W low
+136.30%
Green days (20)
13/20
Monthly seasonality
Average monthly move for LAURUSLABS across the available price history.
Key statistics
Open
1,932.6
Day high
1,950.5
Day low
1,920.9
Prev close
1,945
Volume
10.68 L
Avg vol (20d)
35.36 L
52W high
1,955
52W low
823.1
LAURUSLABS quarterly results
All LAURUSLABS results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹2,026 cr
+29.1% YoY
Net profit
₹368 cr
+125.5% YoY
Operating profit
₹514 cr
+93.9% YoY
EPS
₹6.81
+125.5% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹2,026 cr | ₹514 cr | ₹368 cr | 25.4% | 18.1% | ₹6.81 | +125.5% | +31.7% |
| Q4 FY262026-03-31 | ₹1,812 cr | ₹390 cr | ₹279 cr | 21.5% | 15.4% | ₹5.17 | +19.5% | +10.9% |
| Q3 FY262025-12-31 | ₹1,778 cr | ₹360 cr | ₹252 cr | 20.2% | 14.2% | ₹4.67 | — | +54.4% |
| Q1 FY262025-06-30 | ₹1,570 cr | ₹265 cr | ₹163 cr | 16.9% | 10.4% | ₹3.02 | — | -30.2% |
| Q4 FY252025-03-31 | ₹1,720 cr | ₹310 cr | ₹234 cr | 18.0% | 13.6% | ₹4.34 | — | — |
| TTM (last 4 quarters) | ₹7,186 cr | ₹1,529 cr | ₹1,061 cr | 21.3% | 14.8% | ₹19.67 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.